846 related articles for article (PubMed ID: 31517538)
1. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome and cancer immunotherapy.
Li W; Deng Y; Chu Q; Zhang P
Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
Pandey P; Khan F
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
[TBL] [Abstract][Full Text] [Related]
4. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.
Wang Y; Ma R; Liu F; Lee SA; Zhang L
Front Immunol; 2018; 9():374. PubMed ID: 29556232
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.
Shui L; Yang X; Li J; Yi C; Sun Q; Zhu H
Front Immunol; 2019; 10():2989. PubMed ID: 32010123
[TBL] [Abstract][Full Text] [Related]
9. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
10. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Pitt JM; Vétizou M; Daillère R; Roberti MP; Yamazaki T; Routy B; Lepage P; Boneca IG; Chamaillard M; Kroemer G; Zitvogel L
Immunity; 2016 Jun; 44(6):1255-69. PubMed ID: 27332730
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cancer immunotherapy efficacy by gut microbiota.
Huo S; Liu L; Liu J; Li Q; Wang J
Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity.
Baiden-Amissah REM; Tuyaerts S
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340438
[TBL] [Abstract][Full Text] [Related]
14. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
[TBL] [Abstract][Full Text] [Related]
15. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
Guven DC; Aktas BY; Simsek C; Aksoy S
Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
[TBL] [Abstract][Full Text] [Related]
17. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.
Brandi G; Frega G
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159348
[TBL] [Abstract][Full Text] [Related]
18. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
[TBL] [Abstract][Full Text] [Related]
19. Microbiome and cancer treatment: Are we ready to apply in clinics?
Chan SL
Prog Mol Biol Transl Sci; 2020; 171():301-308. PubMed ID: 32475526
[TBL] [Abstract][Full Text] [Related]
20. Exploring the emerging role of the microbiome in cancer immunotherapy.
Fessler J; Matson V; Gajewski TF
J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
